|
| Antiviral Drugs Advisory Committee (December 2) |
|
| The committee will begin with a closed session from 8 a.m. to 10:30 a.m., to permit discussion and review of trade secret and/or confidential information. Following the closed session, from 10:30 a.m. to 5 p.m., the meeting will be open to the public. The committee will discuss the safety and efficacy of new drug application (NDA) 20-725, Creon (pancrelipase delayed-release capsules), Solvay Pha |
| |
| 0 Comments - More Info - Bury Topic: Health News |
|